Liver inflammation and fibrosis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Investigation

• Publication date

  2017-01-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI88881PMID 28045404PMCID PMC5199698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

  2019cited by this paper
• Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood

  2017cited by this paper
• The Spectrum of Histologic Findings in Hepatic Outflow Obstruction.

  2017cited by this paper
• Increased ratio of neutrophil elastase to α1‐antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis

  2016cited by this paper
• Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

  2016cited by this paper
• A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair.

  2016cited by this paper
• MAIT cells: new guardians of the liver

  2016cited by this paper
• Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner[S]

  2016cited by this paper
• Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver

  2016influential reference
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

  2016cited by this paper
• TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype

  2016cited by this paper
• Quantitative determination of saroglitazar, a predominantly PPAR alpha agonist, in human plasma by a LC-MS/MS method utilizing electrospray ionization in a positive mode.

  2016cited by this paper
• Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

  2016cited by this paper
• Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design.

  2016cited by this paper
• Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1

  2016cited by this paper
• Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.

  2016cited by this paper
• Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.

  2016cited by this paper
• Immunology in the liver — from homeostasis to disease

  2016cited by this paper
• Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

  2016cited by this paper
• Extracellular vesicles in liver pathobiology: Small particles with big impact

  2016cited by this paper
• Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.

  2016cited by this paper
• Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy

  2016cited by this paper
• Prednisolone plus S-adenosil-l-methionine in severe alcoholic hepatitis

  2016cited by this paper
• Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism

  2015cited by this paper
• Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

  2015cited by this paper
• Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice

  2015cited by this paper
• Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)

  2015cited by this paper
• Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

  2015cited by this paper
• Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells.

  2015cited by this paper
• TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.

  2015cited by this paper
• The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

  2015cited by this paper
• Metabolic danger signals, uric acid and ATP, mediate inflammatory cross‐talk between hepatocytes and immune cells in alcoholic liver disease

  2015cited by this paper
• CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

  2015influential reference
• Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.

  2015cited by this paper
• NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.

  2015cited by this paper
• Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

  2015cited by this paper
• Inhibition of type I natural killer T cells by retinoids or following sulfatide‐mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice

  2015cited by this paper
• Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.

  2015cited by this paper
• Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• The Complex Myeloid Network of the Liver with Diverse Functional Capacity at Steady State and in Inflammation

  2015cited by this paper
• Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

  2015cited by this paper
• Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.

  2015cited by this paper
• Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation

  2015cited by this paper
• The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease.

  2014cited by this paper
• Dual role of B7 costimulation in obesity‐related nonalcoholic steatohepatitis and metabolic dysregulation

  2014cited by this paper
• Interactions between the intestinal microbiome and liver diseases.

  2014influential reference
• A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse

  2014cited by this paper
• Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

  2014cited by this paper
• Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

  2014cited by this paper
• Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

  2014cited by this paper
• Infiltrating Monocyte-Derived Macrophages and Resident Kupffer Cells Display Different Ontogeny and Functions in Acute Liver Injury

  2014influential reference
• Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

  2014cited by this paper
• Neurotropin Suppresses Inflammatory Cytokine Expression and Cell Death through Suppression of NF-κB and JNK in Hepatocytes

  2014cited by this paper
• Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice

  2014cited by this paper
• Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet‐induced steatohepatitis

  2014cited by this paper
• Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors

  2014cited by this paper
• M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

  2014cited by this paper
• Effects of oral intake of hydrogen water on liver fibrogenesis in mice

  2014cited by this paper
• Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation

  2014cited by this paper
• Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats

  2013cited by this paper
• Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

  2013cited by this paper
• Serum amyloid P inhibits granulocyte adhesion

  2013cited by this paper
• Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk

  2013cited by this paper
• Clinical grading of intrahepatic cholestasis pregnancy.

  2013cited by this paper
• Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

  2013cited by this paper
• A metagenome-wide association study of gut microbiota in type 2 diabetes

  2012cited by this paper
• Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

  2012cited by this paper
• Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients

  2012cited by this paper
• Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac–derived macrophages

  2012cited by this paper
• Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis.

  2012cited by this paper
• Dendritic cell regulation of carbon tetrachloride–induced murine liver fibrosis regression

  2012cited by this paper
• Dendritic Cells Promote Macrophage Infiltration and Comprise a Substantial Proportion of Obesity-Associated Increases in CD11c+ Cells in Adipose Tissue and Liver

  2012cited by this paper
• Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.

  2012cited by this paper
• Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.

  2012cited by this paper
• Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

  2012cited by this paper
• A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells

  2012cited by this paper
• Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity

  2012cited by this paper
• Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

  2012cited by this paper
• Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

  2012cited by this paper
• Nuclear factor high‐mobility group box1 mediating the activation of toll‐like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice

  2011cited by this paper
• Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis*

  2011cited by this paper
• NKT cells are required to induce high IL‐33 expression in hepatocytes during ConA‐induced acute hepatitis

  2011cited by this paper
• The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice

  2011cited by this paper
• A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

  2011cited by this paper
• Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.

  2011cited by this paper
• Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C

  2011cited by this paper
• Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

  2010cited by this paper
• Normalization of obesity-associated insulin resistance through immunotherapy

  2010cited by this paper
• Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

  2010cited by this paper
• Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis

  2010cited by this paper
• Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

  2010cited by this paper
• Development of Monocytes, Macrophages, and Dendritic Cells

  2010cited by this paper
• Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation

  2010cited by this paper
• Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway

  2010cited by this paper
• The interleukin‐17 pathway is involved in human alcoholic liver disease

  2009cited by this paper
• Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

  2009cited by this paper
• Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage.

  2009cited by this paper
• The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.

  2009cited by this paper
• CCR2 promotes hepatic fibrosis in mice

  2009cited by this paper

• Molecular imaging of immune and fibrosis targets to guide therapy for repair after myocardial infarction.

  2026cites this paper
• Anti-Fibrotic and Anti-Inflammatory Effects of Hesperidin in an Ex Vivo Mouse Model of Early-Onset Liver Fibrosis

  2026cites this paper
• Metformin is associated with the suppression of the TNF-α/iNOS/TIMP-1 axis-mediated liver injury and fibrosis secondary to diabetes.

  2026cites this paper
• Proliferation, migration, and differentiation of circulating ILC precursors in HBV infection-associated fibrosis

  2026cites this paper
• Lysolecithin Attenuates LPS-Induced Acute Liver Injury in Weaned Piglets by Inhibiting M1 Macrophage Polarization via the mTOR-Glycolysis Pathway.

  2026cites this paper
• Mediating role of metabolic dysfunction-associated fatty liver disease in the association between individual-level noise exposure and liver enzymes in Chinese automotive manufacturing workers

  2026cites this paper
• Silent inflammation: a hidden cause of liver fibrosis

  2026influential citation
• The gene regulatory networks shaping macrophage plasticity and altered function in fibrosis

  2026cites this paper
• Chronic inflammation and immune response in hepatocellular carcinoma: a comprehensive literature review

  2026cites this paper
• Polypharmacological Exploration of Petroselinum Crispum for Antifibrotic Therapeutics: from Herb to Hepatoprotection.

  2026cites this paper
• Plant-Derived miR-55 Alleviates Liver Fibrosis by Disrupting the CK2α/SMO Complex and Promoting SMO Ubiquitination

  2026cites this paper
• Combining Spatial Transcriptomics and Machine Learning Unravels Fibroblast-Related Biomarkers in Ulcerative Colitis

  2026cites this paper
• The macrophage opera: from metabolic prolog to oncogenic crescendo in metabolic dysfunction-associated steatotic liver disease.

  2026cites this paper
• Platelets as Context-Dependent Modulators of Hepatic Microvascular Injury in Metabolic Dysfunction-Associated Steatotic Liver Disease.

  2026cites this paper
• Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats

  2026cites this paper
• Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.

  2026cites this paper
• Regulatory T Cells from Concept to Clinic: The 2025 Nobel Prize and Its Implications for Immune-Mediated Diseases and Cancer.

  2026cites this paper
• Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases.

  2026cites this paper
• Single-cell atlas of hepatic cellular plasticity and immune niche reprogramming in liver cirrhosis.

  2026cites this paper
• Neuropilin-1 Acts as a co-receptor of IL-13 to reprogram macrophages in liver fibrosis.

  2026cites this paper
• Progress in research on the hepatoprotective effects of C-21 steroidal glycosides from Baishouwu.

  2026cites this paper
• Bioinformatic and chemoinformatic insights into mRNA and lncRNA dysregulation in metabolically associated fatty liver disease: the role of exercise and antioxidants following air pollution exposure.

  2026cites this paper
• Liver kinome reveals PS1145 as therapeutic agent for mitigating systemic inflammation in alcohol-related liver disease.

  2026cites this paper
• Gene dosage imbalance disrupts systemic metabolism in the Dp16 Down syndrome mouse model

  2026cites this paper
• Insulin Resistance and Inflammation

  2026cites this paper
• Structure-Activity Relationship Guided Design of a Highly Sensitive Turn-on Fluorescent Probe for Imaging Inflammation-Associated-HOCl in Early Liver Fibrosis.

  2026cites this paper
• From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

  2026cites this paper
• Self-assembled Lentinus edodes ergosterol-amyloid fiber hydrogel for zebrafish enteritis mitigation: Role of intestinal flora regulation and metabolomic remodeling

  2026cites this paper
• Herbal intervention targeting NLRP3 inflammasome in the treatment of liver diseases

  2026cites this paper
• Metabolic dysfunction-associated fatty liver disease and liver fibrosis: predictive value of the CALLY index

  2026cites this paper
• A novel therapeutic strategy of obesity from the perspective of SPMs

  2026cites this paper
• Mannosylated fenretinide loaded solid lipid nanoparticles alleviate liver fibrosis

  2025cites this paper
• Homeostatic remodeling platform for reprogramming Iron Intraspatial orientation to reverse liver fibrosis.

  2025cites this paper
• Luteolin for the Treatment of Organ Fibrosis: A Mini Review.

  2025cites this paper
• Ultrasound targeted microbubbles for theranostic applications in liver diseases: from molecular imaging to targeted therapy

  2025cites this paper
• STING-inflammasome axis in autoimmune diseases and inflammation-related disease.

  2025cites this paper
• MBD2 deficiency attenuates CCl4-induced hepatic fibrosis by inhibiting M2 macrophage polarization.

  2025cites this paper
• Network pharmacology based investigation of the multi target mechanisms of Murraya koenigii (curry leaves) in non-alcoholic steatohepatitis (NASH)

  2025cites this paper
• Styela clava methanolic extract protects against alcohol-induced liver injury by inhibiting uclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPK) pathways

  2025cites this paper
• Amniotic fluid reduces liver fibrosis by attenuating hepatic stellate cell activation

  2025cites this paper
• Linalool and linalyl acetate attenuated canonical pathway of NF-κB signaling in HepG2 cells

  2025cites this paper
• NIR Driven Pd/Cerium Oxide Nano‐Heterojunction for Enhanced Salvaging Sepsis Induced Acute Liver Injury via Reprogramming Redox Homeostasis in Synergy with Inducing Autophagy

  2025cites this paper
• Comprehensive characterization of granular fibrotic and cellular features in liver tissue enabled by deep learning models

  2025cites this paper
• Diagnostic value of serum Golgi protein 73 in liver fibrosis and inflammation in patients with autoimmune hepatitis

  2025cites this paper
• From cooperation to collapse: systemic failure in liver disease through a sociological lens

  2025cites this paper
• Hyperferritinemia and the Risk of Liver Fibrosis and Liver-Related Events in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease

  2025cites this paper
• Polydatin-curcumin formulation alleviates CTD-ILD-like lung injury in mice via GABBR/PI3K/AKT/TGF-β pathway

  2025cites this paper
• Enhancement of cigarette smoke extract-induced goblet cell metaplasia and hyperplasia exerted through IL-13 receptor α1 expression.

  2025cites this paper
• Calycosin limits hepatic fibrogenesis via KLF15 dependent repression of P2X7R in thioacetamide-induced hepatic fibrosis.

  2025cites this paper
• TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?

  2025cites this paper
• Diagnostic role of serum Golgi protein 73 as a biomarker for the assessment of significant hepatic fibrosis in patients with chronic hepatitis B infection

  2025cites this paper
• Prevention of Liver Fibrosis and Hepatocellular Carcinoma Using Antiplatelet Drugs: A Systematic Review and Meta-analysis.

  2025cites this paper
• Myeloid loss of scaffolding protein menin promotes liver fibrosis via H3K36me3 reprogramming

  2025cites this paper
• Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis

  2025influential citation
• Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver Cirrhosis

  2025cites this paper
• Emerging vesicular nanosystems capable of effectively targeting hepatocytes.

  2025cites this paper
• Polysaccharide of Atractylodes macrocephala Koidz alleviate LPS-induced inflammatory liver injury by reducing pyroptosis of macrophage via regulating LncRNA GAS5/miR-223-3p/NLRP3 axis

  2025cites this paper
• Salvianolic Acid B Attenuates Liver Fibrosis via Suppression of Glycolysis-Dependent m1 Macrophage Polarization

  2025influential citation
• Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases

  2025cites this paper
• Pericytes in Tissue Fibrosis.

  2025cites this paper
• 3D hESC Exosome‐Derived Circular RNA hsa_circ_0076798 Inhibits M1 Macrophage Inflammatory Response and Alleviates Liver Fibrosis by Suppressing TNF/NF‐κB Pathway Through miR‐1184/DICER1 Axis

  2025cites this paper
• Immunological Landscape and Molecular Therapeutic Targets of the Tumor Microenvironment in Hepatocellular Carcinoma

  2025cites this paper
• Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses.

  2025cites this paper
• Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease

  2025cites this paper
• Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism

  2025cites this paper
• Effects of 3-indoleacrylic acid on alleviating lipopolysaccharide-induced liver inflammatory damage in laying hens

  2025cites this paper
• Immune-endothelial cell crosstalk in hepatic endothelial injury of liver fibrotic mice.

  2025cites this paper
• HIV-1 Amplifies IL-8 Response of Human Stellate Cells to Gram-Positive Microbial Products Via H4K5 Histone Acetylation

  2025cites this paper
• Epithelial Cell Dysfunction in Pulmonary Fibrosis: Mechanisms, Interactions, and Emerging Therapeutic Targets

  2025cites this paper
• A Non-canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver

  2025cites this paper
• Inflammation in Cardiogenic Liver Disease

  2025cites this paper
• Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets

  2025cites this paper
• The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis

  2025cites this paper
• SLC7A11 in Fibrosis: Molecular Mechanisms and Future Prospects

  2025cites this paper
• A novel RELA K119 deacetylation mediated by SIRT7 is a pivotal activator to exacerbate liver inflammation and fibrosis in teleosts

  2025cites this paper
• The hydroalcoholic extract of Nasturtium officinale protectively inhibits apoptotic and inflammatory pathways in hepato- and nephrotoxicity: An in vivo study

  2025cites this paper
• Role and mechanisms of cuproptosis in the pathogenesis of Wilson's disease (Review)

  2025cites this paper
• Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation

  2025cites this paper
• Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders

  2025cites this paper
• Multi-bioluminescence based dynamic imaging of Pseudomonas aeruginosa-induced hepatic inflammation process.

  2025cites this paper
• Inhibitory effects of umbelliferone on carbon tetrachloride-induced hepatic fibrosis in rats through the TGF‑β1‑Smad signaling pathway

  2025cites this paper
• An inverted U-shaped association between high-sensitivity C-reactive protein and the albumin ratio and hepatic steatosis and liver fibrosis: a population-based study

  2025cites this paper
• Liver Sinusoidal Endothelial Cells in the Regulation of Immune Responses and Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease

  2025cites this paper
• Per- and Polyfluoroalkyl Substances as Potentiators of Hepatotoxicity in an Exposome Framework: Current Challenges of Environmental Toxicology.

  2025cites this paper
• Exploration of the Regulatory Mechanism of Inflammasomes in Liver Fibrosis and New Therapeutic Targets

  2025cites this paper
• Hypoxic pregnancy promotes fibrosis and increases stress metabolites in the ovine fetal liver

  2025influential citation
• Downregulated Expression of Serum Exosome-Derived miR-375-3p Alleviates Interface Hepatitis and Promotes Fibrosis Regression in Patients With Chronic Hepatitis B

  2025cites this paper
• Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs

  2025cites this paper
• Biochemical and Molecular Studies on the Role of Celecoxib and Some Related Bipyrazoles in Mitigating Induced Liver Injury in Experimental Animals

  2025cites this paper
• LEADS - a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing.

  2025cites this paper
• Comprehensive study of the murine MASH models' applicability by comparing human liver transcriptomes.

  2025cites this paper
• Contributions of Noncardiac Organ–Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives

  2025cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: Unraveling Connections and Advancing Therapies

  2025cites this paper
• Trends and Hot Spots of Macrophages Linked to Metabolic Syndrome: A Comprehensive Bibliometric and Visualization Analysis (2014–2024)

  2025cites this paper
• GHSR‐Foxo1 Signaling in Macrophages Promotes Liver Fibrosis via Inflammatory Response and Hepatic Stellate Cell Activation

  2025cites this paper
• Bidirectional Role of Pericytes in Ischemic Stroke

  2025cites this paper
• M2 Macrophages-Based Immunotherapy: A New Therapeutic Approach in Liver Fibrosis

  2025cites this paper
• Management of Acute Fatty Liver of Pregnancy: A Retrospective Study of 12 Cases Compared With Data in the Literature

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population

  2025cites this paper
• AMPK agonist AICAR ameliorates maternal hepatic lipid metabolism disorder, inflammation, and fibrosis caused by PM2.5 exposure during pregnancy

  2025cites this paper